Trademark: 79326147
Word
NANOFORM
Status Date
Tuesday, June 20, 2023
Registration Number
7082475
Registration Date
Tuesday, June 20, 2023
Filing Date
Wednesday, April 7, 2021
Published for Opposition
Tuesday, April 4, 2023
40 Providing information relating to material treatment; processing of biopharmaceutical materials for others, namely, custom manufacture of biopharmaceutical materials; custom manufacture of biopharmaceuticals; bioremediation services; custom manufacture of pharmaceuticals; treatment of materials by means of modification of particles using chemical and physical processing and transformation processes, namely, manufacturing of pharmaceuticals; provision of information relating to chemical processing being a type of chemical treatment of materials; custom manufacture of medical devices for others; microencapsulating services provided for others
9 Recorded bioinformatics software for capturing, computing, analyzing and interpreting biological data; apparatus for the transmission of data; apparatus for recording data; laboratory data processing apparatus for use in data collection; recorded data communications software; digital media, namely downloadable audio and video digital recordings that contain chemical properties; electronically prerecorded digital recordings featuring data in the field of science; laboratory equipment, namely an apparatus for detecting particles; laboratory apparatus and instruments, namely, particle size analyzers; laboratory apparatus and instruments, namely, particle flow monitors; recorded interactive databases featuring chemical properties of molecules; downloadable computer software for the management of data; downloadable computer software for analyzing drug particles relating to the medical field; nanoparticle size analysers; recorded computer data storage programs; recorded computer programmes for data processing; electronic data loggers; computer programs, recorded, for use in electronic storage of data; electronic databases in the field of pharmaceutical industry recorded on computer media; recorded computer database search engine software; recorded computer software for database synchronization; computer documentation in electronic form, in the nature of electronic publications, namely, manuals, software documentation being a type of manual, whitepapers, magazines, and articles featuring software design and development, database management, data processing, recorded on computer media; recorded computer databases in the field of pharmaceutical industry; recorded computer database servers in the field of pharmaceutical industry; recorded computer programs for accessing, browsing and searching online databases; recorded computer software for database management; recorded computer software to automate data warehousing; recorded computer software for application and database integration; recorded computer software for creating searchable databases of information and data; recorded computer software for authorising access to data bases; electronic databases recorded on computer media in the field of pharmaceutical industry
1 Active chemical ingredients for use in the manufacture of pharmaceuticals; biochemical substances in the nature of biochemical preparations for scientific purposes; biochemical preparations other than for medical use; biological substances in the nature of biochemical reagents other than for medial or veterinary use; biological activators, namely biochemical catalysts; biological inoculants, namely, biological microorganisms used in fermentation of silage, other than for medical use; biological preparations for use in industry and science; substances in the nature of plant hormones for promoting plant growth; plant growth regulating preparations; preservatives for plants; plant extracts for use in the manufacture of pharmaceuticals; chemicals for the protection of plants in the nature of plant preservatives, other than fungicides, weedkillers, herbicides, insecticides, parasiticides; nanopowders for industrial purposes; all the above goods only in the field of nanotechnology and drug particle engineering
44 Consultancy and information services relating to dispensing of biopharmaceutical products; consultancy and information services in the field of pharmaceutical products; provision of pharmaceutical information; advisory services in the field of pharmaceuticals; medical information services provided via the internet; rental of medical apparatus and installations in the field of medical technology; pharmacy advice, namely, pharmaceutical advice; medical counseling; medical screening; medical information; medical analysis services for the diagnosis and treatment of persons provided by a medical laboratory; providing medical information; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; advisory services relating to medical apparatus and instruments; advisory services relating to medical problems; preparation and dispensing of medications; providing information relating to the preparation and dispensing of medications
42 Scientific analysis in the field of molecular biology; analytical scientific laboratory services; advisory services relating to biochemistry; biochemistry consultancy; biochemical research and analysis; biochemical research and development; biochemical engineering services; research and development services in the field of biochemistry; scientific research relating to biology; biological research and analysis; biomedical research services; biological research laboratory services; biological research development services; biological research, clinical research in the field of pharmaceutical industry and medical research; scientific laboratory services in the nature of preparation of biological samples for testing and analysis in research laboratories; research in the field of biotechnology; consultancy relating to biotechnology; scientific and technological services, namely, scientific testing in the field of biotechnology; scientific research in the field of pharmacogenetics; consultancy relating to research in the field of pharmacogenetics; consultancy pertaining to pharmacology; pharmaceutical products development; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; Testing services for assessing the efficiency of pharmaceuticals; testing of pharmaceuticals; pharmaceutical product evaluation; design of particles in the processing of pharmaceutical solids; scientific laboratory services of a chemical and biological laboratory; conducting clinical trials for others; provision of information and data relating to medical and veterinary research and development; design and development of computer software for use with medical technology; medical and pharmacological research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design and development of medical technology; consultancy relating to pharmaceutical research and development; drug discovery services; inspection of pharmaceuticals; research on the subject of pharmaceuticals; research in the field of molecular sciences; providing on-line non-downloadable software for database management; electronic storage services for archiving databases; services for the provision of technological information, namely, providing technology information in the field of pharmaceutical industry; expert opinion relating to technology, namely, technological consultation in the field of computer databases; providing information about industrial scientific analysis and scientific research services; biotechnological research relating to industry; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research for medical purposes; scientific research in the field of pharmacy; scientific research conducted using databases; providing scientific and technological information; conducting clinical trials for others in the field of pharmaceuticals; providing information about the results of clinical trials for pharmaceutical products; design and development of computer database programs; consultancy relating to the design and development of computer database programs; rental of a database server to third parties; installation, maintenance and updating of database software; reconstruction of database systems for others; design and development of software for database management; database design and development; development, updating and maintenance of software and database systems; server hosting of databases; server hosting of computerized data, files, applications and information; writing of computer programs for medical applications; computer programming in the medical field; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; conducting early evaluations in the field of new pharmaceuticals
The mark consists of the stylized wording "NANOFORM" to the right of a design comprised of three wedges of a circle and seven circles.
Oct 10, 2023
Final Decision Transaction Processed By Ib
Sep 21, 2023
Final Disposition Notice Sent To Ib
Sep 21, 2023
Final Disposition Processed
Sep 20, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jun 20, 2023
Notice Of Registration Confirmation Emailed
Jun 20, 2023
Registered-Principal Register
May 9, 2023
Notification Of Possible Opposition - Processed By Ib
Apr 19, 2023
Notification Of Possible Opposition Sent To Ib
Apr 19, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 5, 2023
Notification Processed By Ib
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
Mar 15, 2023
Notification Of Possible Opposition Sent To Ib
Mar 15, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Mar 2, 2023
Law Office Publication Review Completed
Mar 2, 2023
Assigned To Lie
Feb 14, 2023
Approved For Pub - Principal Register
Feb 14, 2023
Previous Allowance Count Withdrawn
Feb 14, 2023
Approved For Pub - Principal Register
Feb 10, 2023
Teas/Email Correspondence Entered
Feb 9, 2023
Correspondence Received In Law Office
Feb 9, 2023
Teas Response To Office Action Received
Sep 5, 2022
Refusal Processed By Ib
Aug 9, 2022
Notification Of Non-Final Action E-Mailed
Aug 9, 2022
Non-Final Action E-Mailed
Aug 9, 2022
Non-Final Action Written
Jul 6, 2022
Teas/Email Correspondence Entered
Jul 5, 2022
Correspondence Received In Law Office
Jul 5, 2022
Teas Response To Office Action Received
Apr 7, 2022
Attorney Review Completed
Apr 5, 2022
Limitation From The Ib - Request Exam Review
Feb 6, 2022
Refusal Processed By Ib
Jan 28, 2022
Limitation Of Goods Received From Ib
Jan 6, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jan 5, 2022
Refusal Processed By Mpu
Dec 14, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Dec 13, 2021
Non-Final Action Written
Dec 11, 2021
Application Filing Receipt Mailed
Dec 7, 2021
Assigned To Examiner
Dec 7, 2021
New Application Office Supplied Data Entered
Dec 6, 2021
Limitation From Original Application Entered
Nov 18, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
